Inactive Instrument

XpresSpa Group Inc Stock Nasdaq

Equities

US98420U1097

Personal Services

Sales 2022 55.94M Sales 2023 30.11M Capitalization 7.27M
Net income 2022 -32M Net income 2023 -27M EV / Sales 2022 0.04 x
Net cash position 2022 28.08M Net cash position 2023 11.96M EV / Sales 2023 -0.16 x
P/E ratio 2022
-1.04 x
P/E ratio 2023
-0.26 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 96.95%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on XpresSpa Group Inc

Managers TitleAgeSince
Chief Executive Officer 59 19-07-14
Director of Finance/CFO 54 23-07-09
Chief Tech/Sci/R&D Officer - 20-11-30
Members of the board TitleAgeSince
Chief Executive Officer 59 19-07-14
Director/Board Member 64 20-02-02
Chairman 60 16-02-07
More insiders
XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and HyperPointe. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck wellness centers in airports, to airport employees and to the traveling public. Its Treat segment provides access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place, as well as book appointments in the Company’s on-site wellness centers as they reopen. HyperPointe segment provides a range of service and support options for its customers, including technical support services and advanced services.
More about the company